Evidence map›Paper›PMID 38646554›Full record

ArticleFrontiers in medicine2024

Assessment of the appropriateness of stress ulcer prophylaxis use and its determinants among admitted surgical patients at Debre Berhan University Hakim Gizaw Hospital, Ethiopia. A hospital-based cross-sectional study.

Abate Wondesen Tsige, Dessale Abate Beyene, Yehualashet Teshome Wondmkun, Bedilu Linger Endalifer, Habtemariam Alekaw Habteweld, Fissha Assegidew Gebretadik, Aregahegn Adafir Gebeyehu, Belayneh Abebaw Azene, Misganaw Abebaw Alamneh, Daniel Zebene Tesfaye and 5 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abate Wondesen TsigeDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Dessale Abate BeyeneDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Yehualashet Teshome WondmkunDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Bedilu Linger EndaliferDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Habtemariam Alekaw HabteweldDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Fissha Assegidew GebretadikDepartment of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Aregahegn Adafir GebeyehuDepartment of Pharmacy, College of Health Sciences, Debre Berhan Health Science College, Debre Berhan, Ethiopia.
Belayneh Abebaw AzeneDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Misganaw Abebaw AlamnehDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Daniel Zebene TesfayeDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Misganaw Aynalem FeredDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Mandefro Teje GirmaDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Melkamu Belayneh MekonenDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Tigist Yazezew DessieDepartment of Pharmacy, Debre Berhan University Hakim Gizaw Hospital, Debre Berhan, Ethiopia.
Siraye Genzeb AyeleDepartment of Midwifery, School of Nursing and Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pharmacological stress ulcer prophylaxis (SUP) has been recommended for many years to reduce the risk of clinically significant upper gastrointestinal (GI) bleeding caused by stress ulcers (SUs). Stress-related ulcer bleeding in surgical patients significantly increases morbidity and mortality. Therefore, preventing stress-induced hemorrhage is the most appropriate measure for patients who are at increased risk. However, the inappropriate use of SUP has increased in recent years, and its use in Ethiopian surgical patients has not been well studied. Objective: The aim of this study was to assess the appropriateness of SUP use and its determinants among admitted surgical patients at Debre Berhan University Hakim Gizaw Hospital (DBUHGH), Ethiopia. Methods: We randomly selected 230 patients from the whole cross-sectional group of all surgical patients at DBUHGH from 1 February to 30 June 2023. The risk of stress ulcer (SU) development was assessed using the modified American Society of Health-System Pharmacists (ASHP) guidelines. For data analysis, we used SPSS version 25. Results: The mean age of study participants was 47.2 years (SD ± 20.4), and out of the total of 230, 130 (56.5%) were women. Approximately 66% of study participants took inappropriate SUP based on ASHP guidelines criteria. The most commonly used drug class for SUP was histamine-2 receptor blockers 115 (50%). Study participants who have a Charlson Comorbidity Index Score of moderate and GI bleeding have been significantly associated with the inappropriate use of SUP. Conclusion: In our study, inappropriate SUP use was common in the surgical ward of DBUHGH. This may be an area that requires further and more focused working together among clinical pharmacists and medical professionals in an institution-specific SUP protocol that aids clinicians in identifying appropriate candidates for SUP medication.

Indexed as

American Society of Health-System PharmacistsEthiopiastress ulcerstress ulcer prophylaxissurgical patients

Identifiers

PMID38646554
PMCPMC11026640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.